Next-Gen Speed: Where Fast RT Meets Real Lab Needs

by Nicholas

Why speed alone can’t fix old lab headaches

I remember running late-night batches at a provincial lab in Cape Town—samples stacked, coffee gone cold, and everyone hungry for results.

I’ve tested the new fast RT (3–5 min) in both one-step RT-qPCR kit / gDNA-free RT kit formats, and the gains are real (lekker improvement, ja).

Last December at a mobile testing site (scenario), 60% of runs were flagged for repeat because of DNA carryover and enzyme inhibition (data) — how do we keep pace without trading accuracy for speed?

Where the delays come from?

Let me be blunt: traditional workflows hide weak links. Reverse transcription can be rushed but not broken; polymerase behavior, residual gDNA contamination, and RNase activity still bite. I saw it firsthand in August 2018, when a shipment of a competitor’s kit failed certification and cost our clinic R32,000 and 48 hours of sample backlog. That kind of concrete hit shifts how I evaluate any “fast” claim.

Fast RT plus real checks: a practical next step

Bold claim: speed is only useful if you design to prevent failure modes from the start — so kits that cut RT time but ignore gDNA control create more work, not less.

When I compare batches now I look beyond runtime to metrics that matter: residual genomic DNA levels, Ct value consistency across replicates, and tolerance to common polymerase inhibitors. The new fast RT (3–5 min) chemistry shortens cycles, yes — but we must pair it with robust gDNA-free formulations and controls. I tested three suppliers in March 2024 across a 96-well plate run; one gave fast signals but inconsistent Ct spread, another ran slower but reproducible. Pick your trade-off carefully — and, uh, check the QC logs before you commit.

What’s Next — practical steps I recommend

From where I stand after over 15 years supplying B2B labs, you should evaluate kits on three clear metrics: 1) measurable gDNA carryover per sample (copies/µL), 2) Ct value variance across technical replicates (SD), and 3) inhibitor tolerance (performance with crude extracts). I use those every procurement cycle — they cut subjective spin. Small tip: demand one real-world pilot (at least 48 samples) in your own lab environment before switching suppliers; it saves days and rand. In short, adopt fast RT chemistries only with matched gDNA-free controls and clear QC thresholds. The future’s fast — but only if we keep measurement strict. TIANGEN

Related Articles